Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-resection/ablation chemotherapy in metastatic colorectal cancer
DRKS00027138Phase 3Recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin, irinotecan, folinic acid and fluorouracil in colorectal cancer (CRC) and colon cancer (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2021; status: recruiting.
02
Drugs
oxaliplatinirinotecanfolinic acidfluorouracil
03
Conditions
colorectal cancer (CRC)colon cancer
Beyond the preview
Go deeper on DRKS00027138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00027138.